Skip to main content
Lonza Group AG logo

Lonza Group AG — Investor Relations & Filings

Ticker · LONN ISIN · CH1255014495 LEI · 549300EFW4H2TCZ71055 SW Manufacturing
Open in API
Filings indexed 137 across all filing types
Latest filing 2023-03-29 Regulatory Filings
Country CH Switzerland
Listing SW LONN

About Lonza Group AG

https://www.lonza.com/

Lonza Group AG is a global contract development and manufacturing organization (CDMO) that partners with the pharmaceutical, biotech, and nutrition industries. The company provides integrated services that span the entire product lifecycle, from early-phase research and process development to custom, large-scale commercial manufacturing. Its expertise covers a wide range of therapeutic modalities, including mammalian and microbial biopharmaceuticals, small molecules, cell and gene therapies, highly potent active pharmaceutical ingredients (APIs), peptides, and bioconjugates. By combining advanced scientific and technological insights with world-class manufacturing and regulatory expertise, Lonza supports its customers in developing and commercializing innovative medicines and health products for patients worldwide.

Recent filings

Filing Released Lang Actions
Lonza Completes Clinical and Commercial Drug Product Manufacturing Line in Visp (CH)
Regulatory Filings Classification · 100% confidence The document is a press release dated March 29, 2023, announcing the completion of a new clinical and commercial drug product manufacturing line in Visp, Switzerland. It details operational status, capacity expansion, and strategic alignment with Lonza's Drug Product Services (DPS) offering. This type of announcement, focusing on operational milestones, capacity expansion, and strategic updates rather than formal financial results (like 10-K or ER) or management changes (MANG), fits best under a general regulatory announcement or news release category. Since it is not a formal financial report, a proxy statement, or a specific capital event, and it is a standard corporate news release, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for general corporate news that doesn't fit the highly specific financial/governance codes. The length (8406 chars) is substantial enough that it is not merely an announcement *of* a report, but the report itself (a press release).
2023-03-29 English
Lonza Completes Clinical and Commercial Drug Product Manufacturing Line in Visp (CH)
Regulatory Filings Classification · 100% confidence The document is a press release dated March 29, 2023, announcing the completion of a new manufacturing line in Visp, Switzerland, and discussing capacity expansion and investment milestones related to Lonza's Drug Product Services (DPS). This type of announcement, detailing operational achievements, capacity updates, and strategic progress, is characteristic of a general corporate update or news release. It is not a formal regulatory filing like a 10-K, an earnings release (ER) which focuses on financial figures, or a specific shareholder communication (like DEF 14A or DVA). Since it is a general corporate announcement that doesn't fit the highly specific categories (like M&A, Dividend, Director Dealing), the most appropriate classification is the general regulatory/news announcement fallback, RNS, as it is a formal communication released via a news service (EQS News Service). The length is substantial (7385 chars), so it is not an RPA.
2023-03-29 English
Lonza Publishes Invitation to the 2023 Annual General Meeting and 2022 Annual and Sustainability Reports
Report Publication Announcement Classification · 100% confidence The document is an 'Ad hoc announcement' dated March 27, 2023, titled 'Lonza Publishes Invitation to the 2023 Annual General Meeting and 2022 Annual and Sustainability Reports'. It explicitly mentions the 'Annual General Meeting' (AGM) details, including the date, proposed board re-elections, and dividend proposal. It also announces the publication of the '2022 Annual and Sustainability Reports'. Since the primary focus is the announcement of the upcoming AGM and related materials (like the invitation and proposed resolutions), the most fitting primary classification is AGM Information (AGM-R). Although it mentions the publication of the Annual Report (10-K) and Sustainability Report (SR), the document itself is the announcement/invitation for the meeting where these items are discussed or presented, making AGM-R the best fit for this specific communication.
2023-03-27 English
Lonza Publishes Invitation to the 2023 Annual General Meeting and 2022 Annual and Sustainability Reports
AGM Information Classification · 98% confidence The document is an 'Ad hoc announcement' that explicitly states it is announcing the publication of two key items: the '2023 Annual General Meeting (AGM)' details and the '2022 Annual and Sustainability Reports'. Since the document itself is an announcement *about* these events/reports, and not the full reports or the formal AGM materials themselves, it fits the definition of a Report Publication Announcement (RPA). It details the date of the AGM and provides links/mentions of the published Annual Report and Sustainability Report, making RPA the most accurate classification for this type of press release/regulatory notice. If the document were significantly longer and contained the full text of the AGM resolutions or the full financial statements, other codes like AGM-R or 10-K/IR might apply. However, as a notice of publication, RPA is correct.
2023-03-27 English
Lonza Completes Expansion of Conjugation Facility in Visp (CH)
Regulatory Filings Classification · 100% confidence The document is a press release dated February 16, 2023, announcing the completion of an expansion of a bioconjugation facility in Visp, Switzerland. It details operational updates, capacity additions, and includes quotes from management and contact information. This type of announcement, which is a corporate update about operational milestones rather than a required periodic financial filing (like 10-K or IR) or a specific shareholder event material, fits best under the general category for regulatory announcements or news releases that don't fit other specific codes. Since it is a news release about corporate activity and not a formal financial report, Earnings Release (ER), or a specific regulatory filing like DIRS or DIV, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory/corporate news releases not covered elsewhere.
2023-02-16 English
Lonza Completes Expansion of Conjugation Facility in Visp (CH)
Regulatory Filings Classification · 95% confidence The document is a press release dated 16.02.2023 announcing the completion of an expansion of a bioconjugation facility in Visp, Switzerland. It details capacity additions and strategic importance. This type of announcement, which is a corporate update regarding operational milestones and capacity, does not fit neatly into the defined financial reporting categories (10-K, IR, ER, etc.). It is a general corporate announcement. Since it is not a specific filing like a Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), and it is not a transcript (CT) or a formal presentation (IP), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous regulatory announcements that do not fit elsewhere, often including press releases about operational news.
2023-02-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.